Because these drugs affect how the brain processes reward, there may be a possibility that it also can dull pleasurable experiences
Interim Results from Ongoing Phase 2 COURAGE Trial Confirm Potential to Improve the Quality of Semaglutide (GLP-1 receptor agonist)-induced Weight Loss by Preserving Lean Mass
Antioxidant Support Enhances cellular antioxidant defense systems, protecting against oxidative stress and free radical damage associated with aging and chronic disease
Common side effects, such as nausea or gastrointestinal discomfort, often diminish over time as the body adjusts to the medication
PlexusDx's Precision Peptide Genetic Test identifies your GIPR, FTO, and MC4R variants across 14 metabolic pathways, revealing how your genes relate to GLP-1 pathways and appetite regulation
Most patients need 24 treatment sessions, spaced several weeks apart